XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 12,802,091 $ 4,046,937
Accounts receivable, net of allowance of $74 and $0 16,761 0
Unbilled accounts receivable 1,697,576 918,164
Inventory 1,910,123 1,660,710
Investments 0 1,944,464
Prepaid expenses 416,464 153,455
Total Current Assets 16,843,015 8,723,730
Long-Term Assets:    
Equipment, net 182,099 143,079
Intangible asset, net 1,004,957 1,050,022
Total Long-Term Assets 1,187,056 1,193,101
Total Assets 18,030,071 9,916,831
Current Liabilities:    
Accounts payable and accrued expenses 382,027 1,449,582
Deferred revenue 183,060 200,109
Other liabilities 0 13,528
Total Current Liabilities 565,087 1,663,219
Total Liabilities 565,087 1,663,219
Stockholders' Equity    
Preferred stock: 50,000,000 authorized; par value $0.0001 per share, nil issued and outstanding at September 30, 2023 and December 31, 2022 0 0
Common stock: 200,000,000 common shares authorized, par value $0.0001 per share, 132,667,107 and 126,702,545 shares outstanding at September 30, 2023 and December 31, 2022, respectively 13,266 12,669
Additional paid-in capital 30,326,463 16,110,221
Accumulated (deficit) (12,872,333) (7,849,982)
Accumulated other comprehensive loss (2,412) (19,296)
Total Stockholders' Equity 17,464,984 8,253,612
Total Liabilities and Stockholders' Equity $ 18,030,071 $ 9,916,831